Tadalafil
Product Images NDC 63629-7943

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 63629-7943). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F5c8b23e 51e5 4264 8328 437c9d11939a 01

FDA Label Image

F5c8b23e 51e5 4264 8328 437c9d11939a 02

F5c8b23e 51e5 4264 8328 437c9d11939a 02
This text appears to be a table showing the maximum decrease in systolic and diastolic blood pressure when different drugs are coadministered with Tadalafil 20mg. The table also includes mean differences between Tadalafil and Placebo for each drug combination. However, it is not clear what condition or study the table refers to.*
FDA Label Image

F5c8b23e 51e5 4264 8328 437c9d11939a 03

F5c8b23e 51e5 4264 8328 437c9d11939a 03
This is a table that lists the effects of different drugs when co-administered with Tadalafil (dosage not provided). The effects are measured in AUC (Area Under the Curve) and Cmax. Ritonavir, ketoconazole, bosentan, and antacids showed the most significant changes in AUC and Cmax when co-administered with Tadalafil. Dose adjustment is recommended for some of these drugs, and some should be avoided altogether. The table also shows the fold change and 90% CI (Confidence Interval) for each drug.*
FDA Label Image

F5c8b23e 51e5 4264 8328 437c9d11939a 04

FDA Label Image

F5c8b23e 51e5 4264 8328 437c9d11939a 05

FDA Label Image

F5c8b23e 51e5 4264 8328 437c9d11939a 06

FDA Label Image

F5c8b23e 51e5 4264 8328 437c9d11939a 07

F5c8b23e 51e5 4264 8328 437c9d11939a 07
This appears to be a chart or table showing the percentage without clinical worsening for Tadalafil 40 mg and Tadalafil 20 mg compared to a placebo, with a measurement of time in days for clinical worsening. Not enough context is provided to determine the specific context or purpose of this chart.*
FDA Label Image

Label Image (Lbl636297943)

Label Image (Lbl636297943)
The text shows information about a medication called Tadalafil 20mg in the form of brown capsules manufactured by Cipla. It includes details on storage instructions and safety precautions. Additionally, there is data on a package that contains 30 tablets with a specific NDC number, but the expiration date is not specified. The top part of the text appears to be some sort of label with a reference to a bank, but it is unclear how it correlates to the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.